NCT00163046View on ClinicalTrials.gov

A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2006

Conditions
Transient Insomnia
Interventions
DRUG

Gabapentin

Gabapentin 250 mg oral capsule 30 minutes prior to bedtime for 28 days

DRUG

Placebo

Matched placebo 30 minutes prior to bedtime for 28 days

Trial Locations (3)

66212

Pfizer Investigational Site, Overland Park

91206

Pfizer Investigational Site, Glendale

92123

Pfizer Investigational Site, San Diego

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00163046 - A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Biotech Hunter | Biotech Hunter